Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis

Oligonucleotides

Volumn 14, Issue 2, 2004, Pages 100-113

  Coma, Sílvia ^a   Noe, Veronique ^a   Lavarino, Cinzia ^a   Adán, Jaume ^b   Rivas, Manuel ^c   López Matas, Mariana ^c   Pagan, Roser ^c   Mitjans, Francesc ^b   Vilaró, Senén ^a   Piulats, Jaume ^b   Ciudad, Carlos J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Biomedical Research Laboratory   (Spain)

^c Advancell   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; RNA; SMALL INTERFERING RNA; SURVIVIN; VITRONECTIN;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RESEARCH; DRUG SCREENING; DRUG SENSITIVITY; DRUG TARGETING; ENDOTHELIUM CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; APOPTOSIS; CELL CULTURE TECHNIQUES; DOWN-REGULATION; ENDOTHELIAL CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; RNA, SMALL INTERFERING;

EID: 3342954801     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/1545457041526290     Document Type: Article

References (43)

1. ALTIERI, D.C. (2003). Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3, 46-54.
2. ALTSCHUL, S.F., GISH, W., MILLER, W., MYERS, E.W., and LIPMAN, D.J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
3. AMBROSINI, G., ADIDA, C., and ALTIERI, D.C. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921.
4. AMBROSINI, G., ADIDA, C., SIRUGO, G., and ALTIERI, D.C. (1998). Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem. 273, 11177-11182.
5. BERTRAND, J.R., POTTIER, M., VEKRIS, A., OPOLON, P., MAKSIMENKO, A., and MALVY, C. (2002). Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296, 1000-1004.
6. BLANC-BRUDE, O.P., MESRI, M., WALL, N.R., PLESCIA, J., DOHI, T., and ALTIERI, D.C. (2003). Therapeutic targeting of the survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin. Cancer Res. 9, 2683-2692.
7. BROOKS, P.C., CLARK, R.A., and CHERESH, D.A. (1994). Requirement of vascular integrin alpha (v) beta 3 for angiogenesis. Science 264, 569-571.
8. CARVALHO, A., CARMENA, M., SAMBADE, C., EARNSHAW, W.C., and WHEATLEY, S.P. (2003). Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell Sci. 116, 2987-2998.
9. CHAVAKIS, E., and DIMMELER, S. (2002). Regulation of endothelial cell survival and apoptosis during angiogenesis. Arterioscler. Thromb. Vasc. Biol. 22, 887-893.
10. CHIOU, S.K., JONES, M.K., and TARNAWSKI, A.S. (2003). Survivin - An anti-apoptosis protein: Its biological roles and implications for cancer and beyond. Med. Sci. Monit. 9, P125-129.
11. CONWAY, E.M., POLLEFEYT, S., CORNELISSEN, J., DEBAERE, I., STEINER-MOSONYI, M., ONG, K., BAENS, M., COLLEN, D., and SCHUH, A.C. (2000). Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood 95, 1435-1442.
12. DEVERAUX, Q.L., and REED, J.C. (1999). IAP family proteins - Suppressors of apoptosis. Genes Dev 13, 239-252.
13. ELBASHIR, S.M., LENDECKEL, W., and TUSCHL, T. (2001). RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15, 188-200.
14. FRIEDLANDER, M., BROOKS, P.C., SHAFFER, R.W., KINCAID, C.M., VARNER, J.A., and CHERESH, D.A. (1995). Definition of two angiogenic pathways by distinct alpha v integrins. Science 270, 1500-1502.
15. GROSSMAN, D., McNIFF, J.M., LI, F., and ALTIERI, D.C. (1999). Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest. Dermatol. 113, 1076-1081.
16. GUPTA, M.K., and QIN, R.Y. (2003). Mechanism and its regulation of tumor-induced angiogenesis. World J. Gastroenterol. 9, 1144-1155.
17. HAMMOND, S.M., CAUDY, A.A., and HANNON, G.J. (2001). Post-transcriptional gene silencing by double-stranded RNA. Nat. Rev. Genet. 2, 110-119.
18. KAPPLER, M., BACHE, M., BARTEL, F., KOTZSCH, M., PANIAN, M., WURL, P., BLUMKE, K., SCHMIDT, H., MEYE, A., and TAUBERT, H. (2004). Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther. 11(3), 186-193.
19. KAWASAKI, H., TOYODA, M., SHINOHARA, H., OKUDA, J., WATANABE, I., YAMAMOTO, T., TANAKA, K., TENJO, T., and TANIGAWA, N. (2001). Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91, 2026-2032.
20. KIESSLING, F., KARTENBECK, J., and HALLER, C. (1999). Cell-cell contacts in the human cell line ECV304 exhibit both endothelial and epithelial characteristics. Cell Tissue Res. 297, 131-140.
21. LI, F., ACKERMANN, E.J., BENNETT, C.F., ROTHERMEL, A.L., PLESCIA, J., TOGNIN, S., VILLA, A., MARCHISIO, P.C., and ALTIERI, D.C. (1999). Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1, 461-466.
22. LI, F., AMBROSINI, G., CHU, E.Y., PLESCIA, J., TOGNIN, S., MARCHISIO, P.C., and ALTIERI, D.C. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
23. MARUSAWA, H., MATSUZAWA S., WELSH, K., ZOU, H., ARMSTRONG, R., TAMM, I., and REED, J.C. (2003). HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22, 2729-2740.
24. MESRI, M., MORALES-RUIZ, M., ACKERMANN, E.J., BENNETT, C.F., POBER, J.S., SESSA, W.C., and ALTIERI, D.C. (2001). Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am. J. Pathol. 158, 1757-1765.
25. MONTANEZ, E., CASAROLI-MARANO, R.P., VILARO, S., and PAGAN, R. (2002). Comparative study of tube assembly in three-dimensional collagen matrix and on Matrigel coats. Angiogenesis 5, 167-172.
26. O'CONNOR, D.S., GROSSMAN, D., PLESCIA, J., LI, F., ZHANG, H., VILLA, A., TOGNIN, S., MARCHISIO, P.C., and ALTIERI, D.C. (2000a). Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 97, 13103-13107.
27. O'CONNOR, D.S., SCHECHNER, J.S., ADIDA, C., MESRI, M., ROTHERMEL, A.L., LI, F., NATH, A.K., POBER, J.S., and ALTIERI, D.C. (2000b). Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol. 156, 393-398.
28. OLIE, R.A., SIMOES-WUST, A.P., BAUMANN, B., LEECH, S.H., FABBRO, D., STAHEL, R.A., and ZANGEMEISTER-WITTKE, U. (2000). A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 60, 2805-2809.
29. PAPAPETROPOULOS, A., FULTON, D., MAHBOUBI, K., KALB, R.G., O'CONNOR, D.S., LI, F., ALTIERI, D.C., and SESSA, W.C. (2000). Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 275, 9102-9105.
30. PENUELAS, S., ALEMANY, C., NOE, V., and CIUDAD, C.J. (2003). The expression of retinoblastoma and Sp1 is increased by low concentrations of cyclin-dependent kinase inhibitors. Eur. J. Biochem. 270, 4809-4822.
31. RABANAL, M., FRANCH, A., NOE, V., CIUDAD, C.J., CASTELL, M., and CASTELLOTE, C. (2002). Inhibition of CD4 expression by antisense oligonucleotides in PMA-treated lymphocytes. Antisense Nucleic Acid Drug Dev. 12, 399-410.
32. RODRIGUEZ, M., NOE, V., ALEMANY, C., MIRALLES, A., BEMI, V., CARAGOL, I., and CIUDAD, C.J. (1999). Effects of anti-sense oligonucleotides directed toward dihydrofolate reductase RNA in mammalian cultured cells. Int. J. Cancer 81, 785-792.
33. SHARP, P.A. (2001). RNA interference - 2001. Genes Dev. 15, 485-490.
34. SHIN, S., SUNG, B.J., CHO, Y.S., KIM, H.J., HA, N.C., HWANG, J.I., CHUNG, C.W., JUNG, Y.K., and OH, B.H. (2001). An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and caspase-3 and -7. Biochemistry 40, 1117-1123.
35. SKOUFIAS, D.A., MOLLINARI, C., LACROIX, F.B., and MARGOLIS, R.L. (2000). Human survivin is a kinetochore-associated passenger protein. J. Cell. Biol. 151, 1575-1582.
36. SUDA, K., ROTHEN-RUTISHAUSER, B., GUNTHERT, M., and WUNDERLI-ALLENSPACH, H. (2001). Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: Endothelial versus epithelial features. In Vitro Cell Dev. Biol. Anim. 37, 505-514.
37. SUZUKI, A., HAYASHIDA, M., ITO, T., KAWANO, H., NAKANO, T., MIURA, M., AKAHANE, K., and SHIRAKI, K. (2000a). Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 19, 3225-3234.
38. SUZUKI, A., ITO, T., KAWANO, H., HAYASHIDA, M., HAYASAKI, Y., TSUTOMI, Y., AKAHANE, K., NAKANO, T., MIURA, M., and SHIRAKI, K. (2000b). Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19, 1346-1353.
39. TAKAHASHI, Y., TESHIMA, T., KAWAGUCHI, N., HAMADA, Y., MORI, S., MADACHI, A., IKEDA, S., MIZUNO, H., OGATA, T., NOJIMA, K., FURUSAWA, Y., and MATSUURA, N. (2003). Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res. 63, 4253-1257.
40. TAMM, I., WANG, Y., SAUSVILLE, E., SCUDIERO, D.A., VIGNA, N., OLTERSDORF, T., and REED, J.C. (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58, 5315-5320.
41. TARNAWSKI, A.S., and SZABO, I. (2001). Apoptosis-programmed cell death and its relevance to gastrointestinal epithelium: Survival signal from the matrix. Gastroenterology 120, 294-299.
42. TRAN, J., RAK, J., SHEEHAN, C., SAIBIL, S.D., LACASSE, E., KORNELUK, R.G., and KERBEL, R.S. (1999). Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun. 264, 781-788.
43. TU, S.P., JIANG, X.H., LIN, M.C., CUI, J.T., YANG, Y., LUM, C.T., ZOU, B., ZHU, Y.B., JIANG, S.H., WONG, W.M., CHAN, A.O., YUEN, M.F., LAM, S.K., KUNG, H.F., and WONG, B.C. (2003). Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res. 63, 7724-7732.